Results 71 to 80 of about 2,982 (119)

Intrathecal tocilizumab for immune-mediated central nervous system complication after haploidentical hematopoietic stem cell transplantation in children: Two case reports. [PDF]

Heliyon
Gui R, Li Z, Wang J, Zu Y, Zhang B, Zhao J, Song Y, Zhou J.   +7 more
europepmc   +1 more source

Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantation. [PDF]

Haematologica
Bordat J, Kaphan E, Robin M, Xhaard A, De Fontbrune FS, Chevillon F, Socie G, De Latour RP, Michonneau D.   +8 more
europepmc   +1 more source

The current state of tolerance induction in vascularized composite allotransplantation. [PDF]

Curr Opin Organ Transplant
Blades CM, Huang CA, Mathes DW.
europepmc   +1 more source

Effective treatment of acute graft-versus-host disease following liver transplantation using an integrated regimen centered on antithymocyte globulin: a single-center experience. [PDF]

Front Immunol
Zheng Q, Zhang L, Wang H, Abdisamat A, Wang X, Xiao X, Jiang W.   +6 more
europepmc   +1 more source

Efficacy and safety of immunosuppressive therapy versus cyclosporine combined with avatrombopag in older adults with severe aplastic anemia: a multicenter prospective study. [PDF]

Blood Cancer J
Wang L, Ye L, Zhao X, Chen M, Zhang F, Han B.   +5 more
europepmc   +1 more source

Comparison of the efficacy of pre-transplant and post-transplant antithymocyte globulin combined with post-transplant cyclophosphamide for graft-<i>versus</i>-host disease prophylaxis in myeloablative haploidentical peripheral blood stem cell transplantation. [PDF]

Cell Transplant
Jin X, Dong T, Ji J, Liu Z, Kuang P, Li J, Wu Y, Xu J, Wang Z, Zeng J, Xiong Z, Chen X.   +11 more
europepmc   +1 more source

Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis. [PDF]

Ann Hematol
Rauhe KA, Kasprzak A, Schulz F, Nachtkamp K, Strupp C, Kündgen A, Dietrich S, Mayer K, Götze KS, Hofmann WK, Giagounidis A, Gattermann N, Germing U.   +12 more
europepmc   +1 more source

Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation. [PDF]

J Hematol Oncol
Kong X, Xu Z, Wu Y, Tang X, Xue S, Miao M, Han Y, Wang Y, Chen S, Sun A, Qiu H, Wu D, Zhao Y, Chen F.   +13 more
europepmc   +1 more source

Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors. [PDF]

Transpl Int
Deslais M, Koenig A, Buron F, Ouellet G, Rabeyrin M, Picard C, Dijoud F, Snanoudj R, Zaidan M, von Tokarski F, Eddine AJ, Le Quintrec M, Serre JE, Corbel A, Flahault A, Giral M, Masset C, Anglicheau D, Aubert O, Sicard A, Gosset C, Lefaucheur C, Divard G, Mariat C, Monchal Q, Matillon X, Lukaszewicz AC, Dubois V, Morelon E, Thaunat O, Charmetant X.   +30 more
europepmc   +1 more source

Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry. [PDF]

Ann Hematol
Halkes CJM, Koster EAS, Bogers EJM, Heubel-Moenen FCJI, Daenen LGM, Klein SK, Langemeijer SMC, Nur E, Raaijmakers MHG, Snijders TJF, Tjon JML, de Wreede LC.   +11 more
europepmc   +1 more source